COVIDsure DIRECT
COVIDsure DIRECT is a multiplex RT-PCR kit for rapid, accurate detection of SARS-CoV-2 directly from VTM samples, without RNA extraction, using RNA Process Buffer for simplified sample preparation.
Overview
COVIDsure DIRECT is a rapid, multiplex RT-PCR kit designed for direct detection of SARS-CoV-2 from VTM samples. The kit eliminates the need for RNA extraction, allowing detection directly from nasopharyngeal and oropharyngeal swabs. Supplied with RNA Process Buffer (RPB), COVIDsure DIRECT simplifies sample preparation while maintaining high accuracy. The kit is also compatible with RNA extracted from VTM samples of suspected COVID-19 patients.
Features
- Extraction-Free Technology : Detect SARS-CoV-2 directly from VTM samples without RNA extraction.
- Multiplex Detection : Simultaneously targets multiple viral genes for improved accuracy.
- Rapid Turnaround : Streamlined workflow reduces testing time.
- High Sensitivity & Specificity : Reliable detection across varying viral loads.
- Flexible Sample Input : Supports both direct VTM samples and extracted RNA.
Technical Specifications
- Sample Type : Nasopharyngeal swab, Oropharyngeal swab
- Method : Multiplex Real-Time PCR
- Target Genes : Multiple SARS-CoV-2 gene targets
- Sample Preparation : RNA Process Buffer (RPB)
- Turnaround Time : [Insert typical assay time, e.g., 90–120 min]
- Storage Conditions : [Insert kit storage conditions]
- Kit Components : RPB, Master Mix, Primers & Probes, Controls
Benefits
Benefits
- Simplified Workflow : Less hands-on time, fewer steps, and reduced risk of errors.
- Time-Efficient : Faster results accelerate clinical decision-making.
- Resource-Saving : Minimizes requirement for extraction kits and reagents.
- Reliable Performance: Maintains diagnostic accuracy even without RNA extraction.
Inquiry Form